Xeris Biopharma Holdings, Inc. Common Stock
Symbol: XERS (NASDAQ)
0.00
▼ (-100.00%) -7.680
Company Description:
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
Key Stats
- Today's Open: $0
- Today's High: $0
- Today's Low: $0
- Today's Volume: 0
- Yesterday Close: $7.68
- Yesterday High: $7.885
- Yesterday Low: $7.64
- Yesterday Volume: 1.26M
- Last Min Volume: 0
- Last Min High: $0
- Last Min Low: $0
- Last Min VWAP: $0
Company Profile
- Name: Xeris Biopharma Holdings, Inc. Common Stock
- Website: https://www.xerispharma.com
- Listed Date: 2018-06-21
- Location: CHICAGO, IL
- Market Status: Active
- CIK Number: 0001867096
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $1.26B
- Round Lot: 100
- Outstanding Shares: 161.48M
- Asset Type: CS
RECENT FILINGS FOR XERS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-11 | 144 | View |
| 2025-08-29 | 4 | View |
| 2025-08-28 | 144 | View |
| 2025-08-15 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 144 | View |
| 2025-08-12 | 144 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-08-04 | 4 | View |
| 2025-08-04 | 4 | View |
| 2025-06-16 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 4 | View |
| 2025-06-04 | 8-K | View |
| 2025-06-03 | 8-K | View |